BusinessEmbolization Coil helps reduce risks and proves cost-effective, to witness a CAGR of 5.1% during 2018-2024: Energias Market Research Pvt. Ltd.By Nasdaq OMXFeb 26, 2018, 11:56 AM UTC
BusinessEmbolization Coil reduced risks and cost-effectiveness, to witness a CAGR of 4.7% during 2017-2023By Nasdaq OMXNov 7, 2017, 1:56 PM UTC